ImmunoGen, Inc. Insider Trading for February 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ImmunoGen, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ImmunoGen, Inc. for February 2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 25 2019 | IMGN | IMMUNOGEN INC | Enyedy Mark J | Chief Executive Off ... | Sell | S | 5.60 | 51,070 | 285,992 | 483,768 | 534.8 K to 483.8 K (-9.55 %) |
| Feb 25 2019 | IMGN | IMMUNOGEN INC | Ryll Thomas | VP, Technical Opera ... | Sell | S | 5.60 | 11,495 | 64,372 | 87,184 | 98.7 K to 87.2 K (-11.65 %) |
| Feb 25 2019 | IMGN | IMMUNOGEN INC | Wingrove Theresa | VP of Regulatory Af ... | Sell | S | 5.60 | 11,032 | 61,779 | 81,883 | 92.9 K to 81.9 K (-11.87 %) |
| Feb 25 2019 | IMGN | IMMUNOGEN INC | Berkenblit Anna | VP & Chief Medical ... | Sell | S | 5.60 | 16,562 | 92,747 | 118,662 | 135.2 K to 118.7 K (-12.25 %) |
| Feb 25 2019 | IMGN | IMMUNOGEN INC | BARROWS CRAIG | Executive VP, Gener ... | Sell | S | 5.60 | 14,870 | 83,272 | 156,537 | 171.4 K to 156.5 K (-8.68 %) |
| Feb 25 2019 | IMGN | IMMUNOGEN INC | Gregory Richard J. | Executive VP & CSO | Sell | S | 5.60 | 36,643 | 205,201 | 199,413 | 236.1 K to 199.4 K (-15.52 %) |
| Feb 06 2019 | IMGN | IMMUNOGEN INC | Wingrove Theresa | VP of Regulatory Af ... | Option Exercise | A | 4.83 | 58,900 | 284,487 | 58,900 | |
| Feb 04 2019 | IMGN | IMMUNOGEN INC | Ryll Thomas | VP, Technical Opera ... | Option Exercise | A | 5.25 | 221,900 | 1,164,975 | 221,900 | |
| Feb 04 2019 | IMGN | IMMUNOGEN INC | Gregory Richard J. | Executive VP & CSO | Option Exercise | A | 5.25 | 289,150 | 1,518,038 | 289,150 | |
| Feb 04 2019 | IMGN | IMMUNOGEN INC | BARROWS CRAIG | Vice-President,Gene ... | Option Exercise | A | 5.25 | 231,750 | 1,216,688 | 231,750 | |
| Feb 04 2019 | IMGN | IMMUNOGEN INC | Berkenblit Anna | VP & Chief Medical ... | Option Exercise | A | 5.25 | 92,500 | 485,625 | 92,500 | |
| Feb 04 2019 | IMGN | IMMUNOGEN INC | Berkenblit Anna | VP & Chief Medical ... | Option Exercise | A | 5.25 | 256,050 | 1,344,263 | 256,050 | |
| Feb 04 2019 | IMGN | IMMUNOGEN INC | Enyedy Mark J | Chief Executive Off ... | Option Exercise | A | 5.25 | 785,000 | 4,121,250 | 785,000 | |
| Feb 04 2019 | IMGN | IMMUNOGEN INC | Wingrove Theresa | VP of Regulatory Af ... | Option Exercise | A | 5.25 | 126,100 | 662,025 | 126,100 | |
| Feb 04 2019 | IMGN | IMMUNOGEN INC | McKee Blaine H. | EVP & Chief Busines ... | Option Exercise | A | 5.25 | 173,140 | 908,985 | 173,140 | |
| Feb 04 2019 | IMGN | IMMUNOGEN INC | FOSTER DAVID G | V.P.-Fin., Prin. Ac ... | Option Exercise | A | 5.25 | 58,100 | 305,025 | 58,100 |